ENVERIC BIOSCIENCES INC (ENVB)

US29405E2081 - Common Stock

1  -0.02 (-1.96%)

After market: 1 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.0039.91M
Minority Interest Expense
N/AN/AN/AN/AN/A
Cost Of Goods
N/AN/AN/AN/A31.76M
Gross Profit
N/AN/AN/AN/A8.15M
Operating Expenses
18.88M19.97M25.29M5.62M14.48M
Research and Development
7.74M8.03M4.79M170.00KN/A
Selling, General, and Administrative Expenses
10.77M11.61M19.85M5.44M12.21M
Operating Income
-18.88M-19.97M-25.29M-5.62M-6.32M
Interest Income/Expense
1.94M3.14M-10.00K-450.00K-690.00K
Other Income/Expense
360.00K4.32M8.20M-800.00K1.80M
Non Recurring Items
N/A-7.45M-39.33MN/A0.00
Income Before Taxes
-24.02M-19.96M-56.43M-6.86M-5.22M
Income Tax
N/A-1.49M-7.45MN/A390.00K
Net Income
-22.82M-18.80M-48.98M-6.86M-6.03M
EBITDA
-18.53M-19.64M-24.64M-5.50M-4.05M
 
Per Share Data
EPS Diluted Total Ops
-10.87-12.96-104.21-57.16-603.00
 
Statistics
Gross Profit Margin
N/AN/AN/AN/A20.42%
Profit Margin
N/AN/AN/AN/A-15.11%
Operating Profit Margin
N/AN/AN/AN/A-15.84%

All data in USD

Charts